• Completes acquisition of South Korea based Yozma BMTech, strengthening global precision imaging
  strategy
• Unveils BPL Cortex, an AI-powered radiology platform to support faster, smarter diagnosis

BPL Medical Technologies made a strong impact at the 78th Annual Conference of
the diagnostics, and women’s health technologies.

During the conference, the company unveiled a suite of next-generation imaging and digital health solutions
through expert-led launch sessions conducted alongside BPL’s leadership. These launches reflected the company’s
focus on developing scalable, clinically meaningful, and India-centric technologies aligned with real-world
healthcare delivery.

Further strengthening its global imaging and diagnostics capabilities, BPL Medical Technologies completed the
acquisition of Yozma BMTech Co., Ltd., in South Korea, in December 2025. The move underscores BPL’s strategic
focus on precision imaging, global technology integration, and expanding access to advanced diagnostic solutions
within India’s evolving healthcare ecosystem.

The company also announced the launch of BMTech, in the presence of industry expert Mr. Govindarajan, founder
& CEO of Aarthi scans highlighting the role of precision imaging and global technology partnerships in
strengthening India’s diagnostic ecosystem. This was complemented by focused discussions on women’s health
imaging, with emphasis on advancements in bone densitometry and mammography.
Further expanding its AI portfolio, BPL Medical Technologies unveiled BPL Cortex, an AI-powered radiology
platform designed to enhance clinical decision-making, streamline workflows, and improve reporting efficiency.

The company also announced a strategic partnership with 5C Network, India’s AI-native radiology platform, to
jointly develop a groundbreaking OEM-embedded solution within imaging systems for the first time in India.
A key highlight of BPL Medical Technologies’ participation was RIA, a robotic assistant, which hosted multiple
expert-led educational sessions across imaging solutions, women’s health, and AI in radiology. The sessions
witnessed strong engagement from delegates, reflecting growing interest in intelligent, technology-enabled
diagnostic education.

Commenting on the participation, Dr Shravan, Managing Director, BPL Medical Technologies, said, “IRIA provides
a valuable platform to engage directly with the radiology community. Our focus remains on building integrated
imaging and AI solutions that enhance diagnostic confidence while remaining scalable, affordable, and relevant to
India’s healthcare ecosystem.”
BPL Medical Technologies’ participation at IRIA 2026 reaffirmed its commitment to driving innovation that is
clinically impactful, technologically advanced, and aligned with the evolving needs of India’s healthcare landscape.